Search results
Is Bluebird Bio Stock a Buy?
Motley Fool via Yahoo Finance· 5 days agoBeing a highly innovative company isn't a sufficient condition for success in the biotech industry. Bluebird Bio (NASDAQ: BLUE), a small-cap gene-editing...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 4 days agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
New York State Common Retirement Fund Has $263,000 Holdings in bluebird bio, Inc. (NASDAQ:BLUE)
ETF DAILY NEWS· 5 days agoNew York State Common Retirement Fund boosted its holdings in shares of bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 67.0% during the 4th quarter, ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses...
WFRV 5 Green Bay· 6 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
WPRI Providence· 4 days agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against bluebird bio, Inc. ("Blue" or the "Company") (NASDAQ ...
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an...
KTLA-TV Los Angeles· 6 days agoLevi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 12 hours agoNEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc ...
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
WPRI Providence· 5 days agoLOS ANGELES, May 16, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit ...
Bluebird bio Inc [BLUE] stock for 9,311 USD was sold by Obenshain Andrew – Knox Daily
Knox Daily· 5 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bluebird bio Inc shares valued at $9,311 ...
A company insider recently sold 6,095 shares of Bluebird bio Inc [BLUE]. Should You also Consider to...
Knox Daily· 7 days agoBluebird bio Inc’s filing revealed that its President and CEO Obenshain Andrew unloaded Company’s shares for reported $9311.0 on Mar 04 ’24. In the deal ...